This multicentre international randomized trial compared the impact of gadoxetic acid-enhanced magnetic resonance imaging ( MRI ) , MRI with extracellular contrast medium ( ECCM-MRI ) and contrast-enhanced computed tomography ( CE-CT ) as a first-line imaging method in patients with suspected colorectal cancer liver metastases ( CRCLM ) .